Published Date: 13 Mar 2023
When an elderly boater falls into shallow water, an emergency medical attendant leaves the boat and goes to work.
Read Full NewsThe history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.
US radiologists vary substantially in their reading of low-dose CT lung cancer screens, highlighting a need for measures to help standardize interpretation.
Researchers compare first-line chemotherapy regimens in older patients with classical Hodgkin lymphoma to assess whether AVD is associated with better outcomes in routine care.
Researchers analyze individual patient data from five randomized phase 3 trials comparing PORT alone vs PORT plus hormone therapy in patients with recurrent prostate cancer.
A new real-world analysis helps clarify the most informative prognostic PSA benchmark in men with metastatic castration-sensitive prostate cancer.
Tissue-free ctDNA may be comparable to tumor-informed assays in detecting molecular residual disease.
1.
Drugmaker Pulls Trodelvy's Bladder Cancer Approval
2.
Prostate cancer therapies: AI-based image analysis detects early organ damage
3.
Limited Benefit from New Drugs; Significant Increase in Drug Prices; AI Boost for Mammo Results.
4.
June 20, 2023, Health Bulletin No. 12.
5.
Thriving while surviving: Understanding the social needs of cancer survivors
1.
A Mural of Thrombus: Unlocking the Power of Art to Combat Cardiovascular Disease
2.
Strategic Concepts in Hematology for Modern Medicine
3.
Metabolic Plasticity in the Progression of Solid Tumors
4.
Unleashing Precision Medicine: CRISPR-Cas9 Gene Editing in Hematopoietic Stem Cells
5.
Understanding Drug-Induced Cardiotoxicity: Mechanisms, Impact, and Future Directions
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
2.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
3.
Navigating the Complexities of Ph Negative ALL - Part VI
4.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
5.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation